A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice.
Saved in:
| Title: | A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice. |
|---|---|
| Authors: | Mohammad S; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Al Zoubi S; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Basic Medical Sciences, School of Medicine, Al-Balqa Applied University, As-Salt, Jordan., Collotta D; Department of Drug Science and Technology, University of Turin, Turin, Italy., Krieg N; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.; Septomics Research Center, Jena University Hospital, Jena, Germany., Wissuwa B; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.; Septomics Research Center, Jena University Hospital, Jena, Germany., Ferreira Alves G; Department of Drug Science and Technology, University of Turin, Turin, Italy., Purvis GSD; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Sir William Dunn School Pathology, University of Oxford, Oxford, United Kingdom., Norata GD; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.; IRCCS Multimedica, Sesto San Giovanni, Milan, Italy.; Società Italiana per lo Studio della Aterosclerosi (S.I.S.A.) Centre for the Study of Atherosclerosis, Bassini Hospital, Milan, Italy., Baragetti A; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.; IRCCS Multimedica, Sesto San Giovanni, Milan, Italy., Catapano AL; Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.; IRCCS Multimedica, Sesto San Giovanni, Milan, Italy.; Società Italiana per lo Studio della Aterosclerosi (S.I.S.A.) Centre for the Study of Atherosclerosis, Bassini Hospital, Milan, Italy., Solito E; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Universitá degli Studi di Napoli 'Federico II', Napoli, Italy., Zechendorf E; Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany., Schürholz T; Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany., Correa-Vargas W; Forschungszentrum Borstel, Department of Biophysics, Borstel, Germany., Brandenburg K; Brandenburg Antiinfektiva GmbH, c/o Forschungszentrum Borstel, Borstel, Germany., Coldewey SM; Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.; Septomics Research Center, Jena University Hospital, Jena, Germany., Collino M; Department of Neurosciences 'Rita Levi Montalcini', University of Turin, Turin, Italy., Yaqoob MM; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom., Martin L; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany., Thiemermann C; William Harvey Research Institute, Bart's and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2021 Jul 19; Vol. 12, pp. 701275. Date of Electronic Publication: 2021 Jul 19 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2021.701275 |
